|
US6372957B1
(en)
*
|
1998-11-10 |
2002-04-16 |
Board Of Regents, The University Of Texas System |
Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use
|
|
JP2001149081A
(ja)
*
|
1999-11-29 |
2001-06-05 |
Cyclex Co Ltd |
脱アセチル化酵素の活性測定方法、並びにこれら酵素の阻害剤もしくは促進剤のスクリーニング方法
|
|
PE20020354A1
(es)
*
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
US6706686B2
(en)
*
|
2001-09-27 |
2004-03-16 |
The Regents Of The University Of Colorado |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US20040077083A1
(en)
*
|
2002-10-17 |
2004-04-22 |
Isis Pharmaceuticals Inc. |
Antisense modulation of histone deacetylase 4 expression
|
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US20040171118A1
(en)
*
|
2003-02-13 |
2004-09-02 |
City Of Hope |
Methods for directing DNA methylation in mammalian cells using homologous short double stranded RNAs
|
|
US20070104688A1
(en)
|
2003-02-13 |
2007-05-10 |
City Of Hope |
Small interfering RNA mediated transcriptional gene silencing in mammalian cells
|
|
US7375228B2
(en)
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
BRPI0410787A
(pt)
*
|
2003-05-21 |
2006-06-20 |
Univ Texas |
inibição da proteìna cinase c-mu (pkd) como um tratamento para hipertrofia cardìaca e insuficiência cardìaca
|
|
CN1964714B
(zh)
*
|
2003-08-29 |
2011-09-28 |
Hdac默克研究有限责任公司 |
辛二酰苯胺异羟肟酸和吉西他滨在制备用于治疗癌症的药物中的用途
|
|
US20050137234A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005065681A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
|
|
CA2555632A1
(en)
*
|
2004-02-02 |
2005-08-18 |
Myogen, Inc. |
Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
|
|
US20050197336A1
(en)
*
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
|
US7345043B2
(en)
*
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
|
US20050288215A1
(en)
*
|
2004-04-05 |
2005-12-29 |
Mckinsey Timothy A |
Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure
|
|
EP1740945B1
(en)
|
2004-04-07 |
2018-09-19 |
Ncardia AG |
Non-invasive, in vitro functional tissue assay systems
|
|
DK1745144T3
(da)
|
2004-05-11 |
2011-02-07 |
Axiogenesis Ag |
Analysefremgangsmåde til opsporing af lægemidler på grundlag af in vitro-differentierede celler
|
|
FI20040675A0
(fi)
*
|
2004-05-12 |
2004-05-12 |
Orion Corp |
Menetelmä sydämen hypertrofian hoitoon ja estoon
|
|
US20060110390A1
(en)
*
|
2004-08-25 |
2006-05-25 |
Myogen, Inc. |
Inhibition of Ku as a treatment for cardiovascular diseases
|
|
WO2006060382A2
(en)
*
|
2004-11-30 |
2006-06-08 |
Trustees Of The University Of Pennsylvania |
Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
|
|
WO2006066133A2
(en)
|
2004-12-16 |
2006-06-22 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP2008530136A
(ja)
|
2005-02-14 |
2008-08-07 |
ミイカナ セラピューティクス インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物
|
|
US20100087328A1
(en)
*
|
2005-03-01 |
2010-04-08 |
The Regents Of The University Of Michigan |
Brm expression and related diagnostics
|
|
US7604939B2
(en)
*
|
2005-03-01 |
2009-10-20 |
The Regents Of The University Of Michigan |
Methods of identifying active BRM expression-promoting HDAC inhibitors
|
|
JP2008540574A
(ja)
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
US7732475B2
(en)
*
|
2005-07-14 |
2010-06-08 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2007011757A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Myogen, Inc. |
Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
|
|
MX2008001964A
(es)
*
|
2005-08-10 |
2008-03-26 |
Novartis Ag |
Metodo de uso de inhibidores de desacetilasa.
|
|
WO2007059533A2
(en)
*
|
2005-11-18 |
2007-05-24 |
Myogen, Inc. |
Uses for camki i and hdacs in the treatment of heart conditions
|
|
AU2006318652A1
(en)
*
|
2005-11-18 |
2007-05-31 |
Gloucester Pharmaceuticals, Inc. |
Metabolite derivatives of the HDAC inhibitor FK228
|
|
US20070207950A1
(en)
*
|
2005-12-21 |
2007-09-06 |
Duke University |
Methods and compositions for regulating HDAC6 activity
|
|
WO2007084390A2
(en)
*
|
2006-01-13 |
2007-07-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2007126958A2
(en)
*
|
2006-03-29 |
2007-11-08 |
Edward Via Virginia College Of Osteopathic Medicine |
Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
|
|
CA2641951A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Novartis Ag |
Combination of organic compounds
|
|
WO2007120839A2
(en)
|
2006-04-13 |
2007-10-25 |
Wake Forest University Health Sciences |
C-nitroso-derived nitroxyl donors
|
|
EP2049139A4
(en)
*
|
2006-04-24 |
2009-06-24 |
Gloucester Pharmaceuticals Inc |
TREATMENT OF TUMORS EXPRESSING RAS
|
|
WO2007146730A2
(en)
|
2006-06-08 |
2007-12-21 |
Gloucester Pharmaceuticals |
Deacetylase inhibitor therapy
|
|
BRPI0720991A8
(pt)
*
|
2006-12-29 |
2016-03-15 |
Gloucester Pharmaceuticals Inc |
Preparação da romidepsina
|
|
AU2007342030B2
(en)
*
|
2006-12-29 |
2013-08-15 |
Celgene Corporation |
Romidepsin-based treatments for cancer
|
|
US9884031B2
(en)
*
|
2007-05-09 |
2018-02-06 |
The Trustees Of The University Of Pennsylvania |
Use of HDAC inhibitors for treatment of cardiac rhythm disorders
|
|
US7737175B2
(en)
*
|
2007-06-01 |
2010-06-15 |
Duke University |
Methods and compositions for regulating HDAC4 activity
|
|
US9226965B2
(en)
*
|
2007-10-05 |
2016-01-05 |
U.S. Department Of Veterans Affairs |
Method and composition for treating heart failure
|
|
WO2009089598A2
(en)
*
|
2008-01-18 |
2009-07-23 |
Katholieke Universiteit Leuven |
Msmb-gene methylation based diagnosis, staging and prognosis of prostate cancer
|
|
US20100212036A1
(en)
*
|
2008-09-30 |
2010-08-19 |
Olson Eric N |
Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy
|
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
|
SG187032A1
(en)
|
2010-07-12 |
2013-02-28 |
Celgene Corp |
Romidepsin solid forms and uses thereof
|
|
US8859502B2
(en)
|
2010-09-13 |
2014-10-14 |
Celgene Corporation |
Therapy for MLL-rearranged leukemia
|
|
JP6025732B2
(ja)
|
2010-10-13 |
2016-11-16 |
テトラロジック シェイプ ユーケイ エルティーディー |
ヒストンデアセチラーゼ阻害薬のための医薬製剤
|
|
AU2013202506B2
(en)
|
2012-09-07 |
2015-06-18 |
Celgene Corporation |
Resistance biomarkers for hdac inhibitors
|
|
AU2013202507B9
(en)
|
2012-11-14 |
2015-08-13 |
Celgene Corporation |
Inhibition of drug resistant cancer cells
|
|
NZ630311A
(en)
|
2013-12-27 |
2016-03-31 |
Celgene Corp |
Romidepsin formulations and uses thereof
|
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
|
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
|
CA3156303A1
(en)
*
|
2019-10-03 |
2021-04-08 |
Tenaya Therapeutics, Inc. |
5-fluoronicotinamide derivatives and uses thereof
|
|
AU2020407664A1
(en)
|
2019-12-20 |
2022-08-18 |
Tenaya Therapeutics, Inc. |
Fluoroalkyl-oxadiazoles and uses thereof
|
|
EP4333841A1
(en)
|
2021-05-04 |
2024-03-13 |
Tenaya Therapeutics, Inc. |
2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef
|
|
CN116942822A
(zh)
*
|
2023-06-12 |
2023-10-27 |
深圳大学 |
Hdac2在治疗室性心律失常中的应用
|
|
CN118766882B
(zh)
*
|
2024-09-12 |
2025-02-21 |
北京大学第三医院（北京大学第三临床医学院） |
用于治疗心血管疾病的制剂及其应用和制备方法
|